BibTeX
CSL-JSON
MLA
Harvard
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3
release_mpnjkpsb2fdjfikarqnobaq5wq
by
Massimo Cristofanilli,
Angela DeMichele,
Carla Giorgetti,
Nicholas C. Turner,
Dennis J. Slamon,
Seock-Ah Im,
Norikazu Masuda,
Shailendra Verma,
Sherene Loi,
Marco Colleoni,
Kathy Puyana Theall,
Xin Huang
(+2 others)
Archived Files and Locations
application/pdf
798.4 kB
file_6rsh7krt7jclzdqsgj5vojqwbe
| |
application/pdf
796.2 kB
file_ea5levnj45f45omccp6enqx6lu
|
www.ejcancer.com (web) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links
oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar